New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma

This study has been completed.

Study NCT00393952 Information provided by SkyePharma AG

First Received: October 27, 2006 Last Updated: June 8, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2008
Primary Completion Date:	April 2008 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: August 24, 2010